IQVIA Holdings Inc. (NYSE:IQV), a wholly-owned subsidiary of IQVIA Inc., has announced plans to raise $1 billion dollars through an offering of senior secured notes and senior notes due in 2028 and 2030, respectively. This ambitious move will help the company to grow and expand its services to meet the needs of its customers. With this offering, IQVIA is poised to become an even stronger leader in the industry.
The Issuer is pleased to announce the offering of Notes, which is expected to provide the necessary funds to repay existing borrowings under the Issuer’s revolving credit facility and cover fees and expenses related to the Notes offering.
With the successful completion of the Notes offering, the Issuer will be able to make significant strides in its financial goals. Subject to market and other customary conditions, the Issuer is confident that the Notes offering will be a success.
This press release contains forward-looking statements which involve risks, uncertainties, and other factors. These may result in changes to market conditions and could lead to the failure of the Notes offering. Actual results may differ materially from those projected.
We are pleased to announce the offering of Notes to qualified institutional buyers in the United States in reliance on Rule 144A under the Securities Act and to non-U.S. investors pursuant to Regulation S under the Securities Act. This offering of Notes does not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any offer, solicitation or sale of the Notes in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful.
The Notes have not been registered under the Securities Act of 1933, as amended (the “Securities Act”), or the securities laws of any other jurisdiction and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act. Any offer of the Notes will be made only by means of a private offering memorandum.
IQVIA (NYSE:IQV) is revolutionizing healthcare with advanced analytics, transformative technology, and cutting-edge clinical research services. Our Connected Intelligence™ platform provides powerful insights and accelerates the development of innovative treatments that improve healthcare outcomes for patients.
With over 87,000 employees located in more than 100 countries, IQVIA is a leader in the life sciences industry, connecting all aspects of healthcare and helping to shape the future of healthcare.
IQVIA is dedicated to protecting individual patient privacy and upholding the highest standards of data security. With robust technologies and safeguards in place, IQVIA provides healthcare stakeholders access to unprecedented insights about diseases, behaviors, and scientific breakthroughs.
Leveraging this data, biotech, medical device, and pharmaceutical companies, medical researchers, government agencies, and payers can identify patterns, determine the best treatment paths, and move closer to finding cures.